Inhibrx Biosciences Inc.

07/22/2026 | Press release | Archived content

2026 Musculoskeletal Tumor Society (MSTS) Annual Meeting2026 European Society for Medical Oncology (ESMO) Congress (MSTS 2026 ChonDRAgon Secondary Endpoints AbstractHexAgon-HN[...]

Inhibrx Biosciences Inc. published this content on July 22, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 29, 2026 at 13:23 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]